SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.459
EU - Europa 3.497
AS - Asia 2.846
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 2
OC - Oceania 2
Totale 23.840
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.432
CN - Cina 1.421
UA - Ucraina 993
SG - Singapore 597
TR - Turchia 593
DE - Germania 550
IT - Italia 526
GB - Regno Unito 426
PL - Polonia 345
SE - Svezia 245
FI - Finlandia 226
VN - Vietnam 96
ID - Indonesia 73
FR - Francia 69
BE - Belgio 31
NL - Olanda 25
BR - Brasile 23
CA - Canada 23
RU - Federazione Russa 23
IR - Iran 17
KR - Corea 13
HK - Hong Kong 10
IN - India 9
AT - Austria 6
CZ - Repubblica Ceca 6
GR - Grecia 5
JP - Giappone 5
LT - Lituania 5
EU - Europa 4
RO - Romania 4
MY - Malesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
IE - Irlanda 2
MX - Messico 2
RS - Serbia 2
SS - ???statistics.table.value.countryCode.SS??? 2
AM - Armenia 1
CL - Cile 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
UZ - Uzbekistan 1
Totale 23.840
Salva come PNG Salva come JPEG
Città #
Fairfield 2.681
Woodbridge 2.480
Houston 1.559
Ashburn 1.237
Jacksonville 1.139
Seattle 1.049
Chandler 991
Ann Arbor 892
Wilmington 877
Cambridge 857
Santa Clara 446
Singapore 439
Izmir 412
Warsaw 341
Nanjing 334
Princeton 251
San Diego 231
Beijing 214
Boardman 194
Ferrara 142
Addison 121
Milan 110
Dong Ket 96
Nanchang 94
Shanghai 93
Los Angeles 91
Shenyang 91
New York 81
Dearborn 76
Jakarta 72
Hebei 68
Mountain View 59
Tianjin 59
Jinan 56
Bremen 55
Jiaxing 52
Falls Church 40
Kunming 40
Changsha 39
London 39
Redwood City 39
Norwalk 35
San Mateo 35
Hangzhou 32
Zhengzhou 32
Brussels 29
Tappahannock 28
Guangzhou 27
Orange 27
Munich 26
Des Moines 25
Ningbo 25
Verona 24
Auburn Hills 23
Taizhou 22
Washington 21
Hefei 19
Philadelphia 18
Indiana 14
Chicago 13
Lanzhou 13
Toronto 13
Augusta 11
Changchun 11
Helsinki 10
Hong Kong 10
Rome 10
Hounslow 9
Redmond 9
Frankfurt am Main 7
Kilburn 7
Monmouth Junction 7
Amsterdam 6
Bologna 6
Leawood 6
Ottawa 6
Vienna 6
Ardabil 5
Berkeley 5
Napoli 5
Padova 5
Tallahassee 5
Brno 4
Cagliari 4
Casalecchio Di Reno 4
Guiyang 4
Haikou 4
Naples 4
Palermo 4
Pavia 4
Prescot 4
Sant'Elpidio a Mare 4
Thessaloníki 4
Walnut 4
Wenzhou 4
Acton 3
Capo D'orlando 3
Chiswick 3
Chongqing 3
Columbus 3
Totale 18.951
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 233
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 177
Loss of miR-204 expression is a key event in melanoma 171
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 167
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 166
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 162
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 161
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 159
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 159
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 157
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 154
Identification of microRNA activity by Targets' Reverse EXpression. 154
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 152
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 149
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 149
MicroRNA e cancro 149
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 149
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 148
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 147
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 146
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 145
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. 145
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. 143
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 142
null 139
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 138
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 138
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 138
MicroRNA involvement in hepatocellular carcinoma 135
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 135
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 135
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. 135
null 132
MicroRNA expression profiling in human Barrett's carcinogenesis. 132
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 131
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 131
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 131
Knockout mice reveal a tumor suppressor function for Testin 130
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 130
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 129
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 129
null 128
null 128
MicroRNA genes are frequently located near mouse cancer susceptibility loci 127
null 127
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 127
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 127
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 126
A microRNA DNA methylation signature for human cancer metastasis 125
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 125
Tumor suppressor functions of ARLTS1 in lung cancers 125
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 124
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. 123
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 123
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 123
null 122
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 122
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 122
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. 121
Reprogramming of miRNA networks in cancer and leukemia 120
null 119
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 119
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 119
Extensive modulation of a set of microRNAs in primary glioblastoma 117
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 117
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. 116
null 116
MicroRNA deregulation in human thyroid papillary carcinomas 116
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 115
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 115
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 115
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 115
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 114
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 114
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 114
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 114
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 112
The role of microRNA genes in papillary thyroid carcinoma 112
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 112
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 112
null 111
MicroRNAs 221 and 222 bypass quiescence and compromise cell survival 111
null 111
A microRNA signature of hypoxia 111
TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos 110
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 109
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 109
Oncogenic role of miR-483-3p at the IGF2/483 locus 109
Mammalian microRNAs: a small world for fine-tuning gene expression 109
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 109
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 109
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 108
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 108
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 108
microRNA involvement in hepatocellular carcinoma 107
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 107
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 106
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 106
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 106
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 106
Totale 12.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 845
Totale 103.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.698 0 0 0 0 454 704 547 611 527 519 197 139
2020/20213.520 274 369 191 408 211 340 155 389 98 406 401 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20251.341 144 94 387 137 579 0 0 0 0 0 0 0
Totale 24.158